Immediate Impact
13 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Works of Ottavia Amato being referenced
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment
2022
Evolution of HER2-low expression from primary to recurrent breast cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ottavia Amato | 206 | 117 | 76 | 113 | 12 | 249 | |
| Eileen Wrabel | 214 | 71 | 53 | 139 | 13 | 267 | |
| Danai Fimereli | 203 | 135 | 67 | 79 | 9 | 281 | |
| SM Swain | 232 | 131 | 65 | 109 | 21 | 281 | |
| Marcelle Goldner Cesca | 216 | 95 | 74 | 87 | 17 | 259 | |
| Debora De Bartolo | 196 | 101 | 71 | 116 | 10 | 257 | |
| Ning Liao | 174 | 123 | 80 | 50 | 21 | 259 | |
| Aurélie Maran-Gonzalez | 159 | 117 | 82 | 44 | 16 | 249 | |
| Hans Wildiers | 155 | 46 | 71 | 44 | 9 | 186 | |
| Fanglei You | 194 | 88 | 30 | 93 | 9 | 296 | |
| Vicente Carañana | 222 | 125 | 87 | 27 | 19 | 256 |
All Works
Login with ORCID to disown or claim papers
Loading papers...